Autonomic tone as a cardiovascular risk factor: The dangers of chronic fight or flight

被引:289
作者
Curtis, BM
O'Keeffe, JH
机构
[1] St Lukes Hosp, Mid Amer Heart Inst, Kansas City, MO 64111 USA
[2] Univ Missouri, Kansas City, MO 64110 USA
关键词
D O I
10.4065/77.1.45
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chronic imbalance of the autonomic nervous system is a prevalent and potent risk factor for adverse cardiovascular events, including mortality. Although not widely recognized by clinicians, this risk factor is easily assessed by measures such as resting and peak exercise heart rate, heart rate recovery after exercise, and heart rate variability. Any factor that leads to inappropriate activation of the sympathetic nervous system can be expected to have an adverse effect on these measures and thus on patient outcomes, while any factor that augments vagal tone tends to improve outcomes. Insulin resistance, sympathomimetic medications, and negative psychosocial factors all have the potential to affect autonomic function adversely and thus cardiovascular prognosis. Congestive heart failure and hypertension also provide important lessons about the adverse effects of sympathetic predominance, as well as illustrate the benefits of beta-blockers and angiotensin-converting enzyme inhibitors, 2 classes of drugs that reduce adrenergic tone. Other interventions, such as exercise, improve cardiovascular outcomes partially by increasing vagal activity and attenuating sympathetic hyperactivity.
引用
收藏
页码:45 / 54
页数:10
相关论文
共 131 条
[1]   Triggering of sudden death from cardiac causes by vigorous exertion [J].
Albert, CM ;
Mittleman, MA ;
Chae, CU ;
Lee, IM ;
Hennekens, CH ;
Manson, JE .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (19) :1355-1361
[2]   Effect of long-acting and short-acting calcium antagonists on cardiovascular outcomes in hypertensive patients [J].
Alderman, MH ;
Cohen, H ;
Roque, R ;
Madhavan, S .
LANCET, 1997, 349 (9052) :594-598
[3]  
*ALLHAT COLL RES G, 2000, JAMA-J AM MED ASSOC, V283, P1697
[4]   HYPERINSULINEMIA PRODUCES BOTH SYMPATHETIC NEURAL ACTIVATION AND VASODILATION IN NORMAL HUMANS [J].
ANDERSON, EA ;
HOFFMAN, RP ;
BALON, TW ;
SINKEY, CA ;
MARK, AL .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (06) :2246-2252
[5]  
Athyros VG, 1998, ACTA CARDIOL, V53, P201
[6]   The risk of myocardial infarction associated with inhaled β-adrenoceptor agonists [J].
Au, DH ;
Lemaitre, RN ;
Curtis, JR ;
Smith, NL ;
Psaty, BM .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 161 (03) :827-830
[7]   β-agonists:: What is the evidence that their use increases the risk of asthma morbidity and mortality? [J].
Beasley, R ;
Pearce, N ;
Crane, J ;
Burgess, C .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 104 (02) :S18-S30
[8]  
BERGMANN CF, 2001, CARDIOL TODAY NOV, V4, P24
[9]   EMOTIONAL SUPPORT AND SURVIVAL AFTER MYOCARDIAL-INFARCTION - A PROSPECTIVE, POPULATION-BASED STUDY OF THE ELDERLY [J].
BERKMAN, LF ;
LEOSUMMERS, L ;
HORWITZ, RI .
ANNALS OF INTERNAL MEDICINE, 1992, 117 (12) :1003-1009
[10]  
Bijnen FCH, 1996, AM J EPIDEMIOL, V143, P553